Skip to main content
Indrayani Biotech Ltd. logo

Indrayani Biotech Ltd. — Investor Relations & Filings

Ticker · 526445 ISIN · INE007C01021 LEI · 984500B6D98BS81M8F53 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 4 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country IN India
Listing BSE.NS 526445

About Indrayani Biotech Ltd.

https://indrayani.com/

Indrayani Biotech Ltd. is a diversified business entity with operations spanning healthcare, food and hospitality, agriculture, and engineering. Originally established with a focus on biotechnology and floriculture, the company has expanded its portfolio through strategic acquisitions and partnerships. In the healthcare segment, it provides diagnostic services and medical equipment. Its food division focuses on dairy products and organized retail. The agricultural arm continues to engage in biotech-driven farming solutions. Additionally, the company operates in the engineering and infrastructure space, offering specialized technical services. Indrayani Biotech emphasizes a multi-disciplinary approach to business, leveraging technology and innovation to cater to diverse market needs while maintaining a focus on sustainable growth and operational excellence across its various subsidiaries and business units.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the year ended 31st March, 2026
Regulatory Filings Classification · 92% confidence The document is titled “Annual Secretarial Compliance Report” prepared by a Practicing Company Secretary under SEBI (LODR) Regulation 24A. It is not a financial statement (10-K, IR, ER), audit opinion (AR), or investor presentation (IP); rather it is a statutory compliance certificate/filing submitted to the stock exchange. It therefore falls under the general category of Regulatory Filings (RNS) as a compliance report under securities regulations.
2026-05-27 English
Delay in financial results for the year ended 31st March, 2026
Regulatory Filings Classification · 87% confidence The document is an exchange filing to BSE under Regulation 33 of SEBI LODR informing of a delay in submission of audited financial results and deferring the board meeting. It does not contain actual financial results, a proxy, dividend notice, management changes, or other specific content categories. It is a general regulatory disclosure, so it falls under Regulatory Filings (RNS).
2026-05-27 English
Resignation letter of Mr. Indirakumar
Board/Management Information Classification · 90% confidence The document is an official disclosure under SEBI LODR Regulation 30 and BSE listing requirements providing the resignation letter of a Whole-Time Director. It is announcing a change in the company’s board/senior management, not a full report or transcript. Therefore, it falls under Board/Management Information.
2026-05-27 English
Outcome of the Rights Issue Committee Meeting held on 25th May, 2026
Share Issue/Capital Change Classification · 94% confidence The document is an exchange filing to the stock exchange notifying shareholders of schedule revisions to a partly paid-up Rights Issue, detailing new opening/closing dates and renunciation deadlines. This is an announcement of a share issuance/capital change. It does not contain full financial data or results, but specifically updates on the company’s Rights Issue (a share capital change). Therefore, it falls under Share Issue/Capital Change (SHA).
2026-05-25 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.